Last update 26 Jul 2025

Aceclidine/Tropicamide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Tropicamide/aceclidine, PRX 100, PRX-100
Target
adrenergic receptor
Action
agonists
Mechanism
adrenergic receptor agonists(Adrenergic receptors agonists)
Therapeutic Areas
Eye Diseases
Active Indication-
Inactive Indication
Presbyopia
Originator Organization
LENZ Therapeutics, Inc.LENZ Therapeutics, Inc.
Active Organization-
Inactive Organization
LENZ Therapeutics, Inc.LENZ Therapeutics, Inc.
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC17H20N2O2
InChIKeyBGDKAVGWHJFAGW-UHFFFAOYSA-N
CAS Registry1508-75-4
View All Structures (2)

Related

2
Clinical Trials associated with Aceclidine/Tropicamide
NCT03201562
/ CompletedPhase 2
A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
NCT02554396
/ CompletedPhase 2
A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 (Aceclidine/Tropicamide) Ophthalmic Topical Formulation in the Treatment of Early to Moderate Presbyopia
100 Clinical Results associated with Aceclidine/Tropicamide
Login to view more data
100 Translational Medicine associated with Aceclidine/Tropicamide
Login to view more data
100 Patents (Medical) associated with Aceclidine/Tropicamide
Login to view more data
100 Deals associated with Aceclidine/Tropicamide
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
PresbyopiaPhase 2
United States
LENZ Therapeutics, Inc.LENZ Therapeutics, Inc.
01 Sep 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT03201562 (CTgov)
Phase 2
Presbyopia
58
(Aceclidine+Tropicamide Combination)
nruddphjht = hfovvbakdx qcstqdmtxt (czbovxbjae, acvnszbmwm - rwhejxaaum)
View more
-
19 Apr 2021
(Aceclidine)
nruddphjht = wugboocnjl qcstqdmtxt (czbovxbjae, unrtzutyly - smfktbjulf)
View more
NCT03201562 (Biospace)
ManualManual
Phase 2
Presbyopia
58
Aceclidine+Tropicamide
qxomtgfvky(sizioftnfx) = neihabvuyg fbpjcaayrc (gylyhrgxge )
View more
Positive
30 Jul 2018
Placebo
-
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free